文献速递产科母胎医学

胎盘与子痫前期:元凶还是受害者?

The placenta and preeclampsia: villain or victim?
PubMed 文献 · Am J Obstet Gynecol · 2021-03-24

该文重新审视子痫前期的病因,指出尽管专家共识倾向于原发性胎盘疾病假说,但新证据表明母体心血管功能不佳导致子宫胎盘低灌注可能是继发性胎盘功能障碍的原因。

要点

  • 母体心血管功能不佳可能是子痫前期胎盘功能障碍的上游原因
  • 心血管功能障碍先于子痫前期临床发病数周至数月

核心结论

  • 子痫前期可能源于母体心血管功能不佳导致的子宫胎盘低灌注,而非单纯原发性胎盘疾病。

研究设计与样本

  • 原文未报告研究设计与样本量,为叙述性综述或专家观点文章。

主要发现

  • 子痫前期与心血管疾病共享危险因素,既存心血管疾病是最强危险因素。
  • 母体超声心动图和血管生成标志物研究数据表明心血管功能障碍先于子痫前期数周或数月。
  • 子痫前期临床表现以心血管体征和症状为主,并持续至产后。
  • 产后十年慢性高血压风险为30%。

关键数值与推荐

  • 原文未报告具体阈值、剂量或推荐条款。

临床怎么用

  • 子痫前期预防策略中心血管药物(阿司匹林、钙剂、他汀类、二甲双胍和降压药)占主导,支持心血管病因假说。
  • 需关注子痫前期患者产后心血管后遗症,但敏感筛查、可靠诊断和有效干预策略仍在发展中。

局限性

  • 子痫前期真正病因仍缺乏一致共识,将临床流行病学发现与器官功能障碍联系起来的生物学机制尚不明确。
  • 原文未报告系统检索范围或证据等级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Preeclampsia is a disease whose characterization has not changed in the 150 years since the cluster of signs associated with the disorder were first described. Although our understanding of the pathophysiology of preeclampsia has advanced considerably since then, there is still little consensus regarding the true etiology of preeclampsia. As a consequence, preeclampsia has earned the moniker "disease of theories," predominantly because the underlying biological mechanisms linking clinical epidemiologic findings to observed organ dysfunction in preeclampsia are far from clear. Despite the lack of cohesive evidence, expert consensus favors the hypothesis that preeclampsia is a primary placental disorder. However, there is now emerging evidence that suboptimal maternal cardiovascular performance resulting in uteroplacental hypoperfusion is more likely to be the cause of secondary placental dysfunction in preeclampsia. Preeclampsia and cardiovascular disease share the same risk factors, preexisting cardiovascular disease is the strongest risk factor (chronic hypertension, congenital heart disease) for developing preeclampsia, and there are now abundant data from maternal echocardiography and angiogenic marker studies that cardiovascular dysfunction precedes the development of preeclampsia by several weeks or months. Importantly, cardiovascular signs and symptoms (hypertension, cerebral edema, cardiac dysfunction) predominate in preeclampsia at clinical presentation and persist into the postnatal period with a 30% risk of chronic hypertension in the decade after birth. Placental malperfusion caused by suboptimal maternal cardiovascular performance may lead to preeclampsia, thereby explaining the preponderance of cardiovascular drugs (aspirin, calcium, statins, metformin, and antihypertensives) in preeclampsia prevention strategies. Despite the seriousness of the maternal and fetal consequences, we are still developing sensitive screening, reliable diagnostic, effective therapeutic, or improvement strategies for postpartum maternal cardiovascular legacy in preeclampsia. The latter will only become clear with an acceptance and understanding of the cardiovascular etiology of preeclampsia.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Melchiorre K, Giorgione V, Thilaganathan B, et al. The placenta and preeclampsia: villain or victim? Am J Obstet Gynecol. 2021. PMID: 33771361. doi:10.1016/j.ajog.2020.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。